Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HHS BARDA
MedTech
FDA clears Aptitude’s Metrix molecular dx to test for COVID
The FDA granted Aptitude its first 510(k) clearance for the California-based dx-maker's next-generation Metrix COVID test.
Joseph Keenan
Sep 18, 2026 8:55am
Fierce Pharma
Cidara snares BARDA award to boost R&D, production of flu asset
Oct 3, 2025 10:10am
HHS unveils $500M universal vaccine development initiative
May 1, 2025 2:55pm
HHS lifts stop work order on Vaxart's COVID-19 trial
Apr 28, 2025 12:48pm
Vaxart lays off staffers after HHS demands halt to vaccine trial
Mar 21, 2025 8:36am
Icon to conduct government trial of next-gen COVID-19 vaccines
Sep 13, 2023 10:27am
